SMNR
SMNR
US81686G1058
Semnur Pharmaceuticals Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
160.416.000 4.690.000
3320.4%
Operating Income -160.416.000 -4.690.000
3320.4%
Pretax Income -160.416.000 -4.690.000
3320.4%
Net Income Common Stockholders -160.416.000 -4.690.000
3320.4%
-- --
--
-- --
--
ende